Entities / Company
Arvinas (United States).
company in New Haven, United States
- Reports this week
- 0
- Active events
- 1
- Connections
- 28
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
Gone quiet
No new reports in 90+ days-
John Houston led Arvinas through significant industry firsts and remains on the company's board.Speculative1 report
-
Arvinas stock benefits from Trump-era tariffs following the EHA 2025 Congress held in Milan, Italy.Some support1 report
-
Arvinas was classified in the Zacks Medical - Biomedical and Genetics industry and underperformed the S&P 500 this year.Some support1 report
-
Arvinas reported that its revenue lagged industry growth expectations in August 2025.Some support1 report
-
Arvinas and Pfizer are jointly developing vepdegestrant for breast cancer and seeking FDA acceptance for the NDA.Some support1 report
-
Pfizer and Arvinas announced a partnership to co-develop Vepdegestrant.Some support3 reports
-
Arvinas, headquartered in New Haven, connects on LinkedIn.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Arvinas (United States) this week
News at the entities that move Arvinas (United States) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Arvinas (United States)
-
Pfizer StructuralDave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Moves Arvinas (United States)
-
New Haven Shared contextCoastal flooding is possible in Fairfield and New Haven counties, while Middlesex counties face high wind warnings.Moves Arvinas (United States)
Connections
The 4 strongest of 28, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Pfizer Structural
Pfizer and Arvinas maintain a formal partnership to co-develop and submit vepdegestrant for breast cancer treatment.
-
John Houston Structural
John Houston serves as the CEO and President of Arvinas.
-
FDA Structural
FDA formally regulates Arvinas's drug development and market approval processes.
-
New Haven Shared context
Arvinas is headquartered in New Haven.
History
Events by the month they beganJune 2026
9 events- Trump pledged to unleash American oil and gas production, involving LCNB National Bank.
- Study results regarding a drug collaboration between Pfizer and Arvinas narrowed the focus to a specific subset of patients.
- John Houston led Arvinas through significant industry firsts and remains on the company's board.
- Arvinas stock benefits from Trump-era tariffs following the EHA 2025 Congress held in Milan, Italy.
- Arvinas was classified in the Zacks Medical - Biomedical and Genetics industry and underperformed the S&P 500 this year.
- Arvinas reported that its revenue lagged industry growth expectations in August 2025.
- Arvinas and Pfizer are jointly developing vepdegestrant for breast cancer and seeking FDA acceptance for the NDA.
- Pfizer and Arvinas announced a partnership to co-develop Vepdegestrant.
- Arvinas, headquartered in New Haven, connects on LinkedIn.